Literature DB >> 9932568

A randomized comparison of extra-amniotic saline infusion and intracervical dinoprostone gel for cervical ripening.

J B Goldman1, T R Wigton.   

Abstract

OBJECTIVE: To compare extra-amniotic saline infusion to intracervical dinoprostone gel for preinduction cervical ripening.
METHODS: Women with Bishop scores less than 5 were assigned randomly to either extra-amniotic saline infusion (n = 26) or intracervical dinoprostone gel (n = 26) for preinduction cervical ripening. A sample size of 50 would have 80% power to detect a 10-hour difference in the mean time from start of cervical ripening to delivery for the two methods of intervention, with a type I error of .05.
RESULTS: The study populations were similar in age, gestational age, and initial Bishop score. They differed in parity, with 22 nulliparas in the extra-amniotic saline infusion group versus 13 in the dinoprostone gel group (relative risk [RR] 1.69, 95% confidence interval [CI] 1.11, 2.57). The number of women achieving a favorable Bishop score at 6 hours was greater with extra-amniotic saline infusion (n = 20) than dinoprostone gel (n = 9) (RR 2.14, 95% CI 1.22, 3.75). Mean time from start of ripening to delivery was 25.9 hours with extra-amniotic saline infusion and 30.2 hours with dinoprostone gel (P = .25). Birth weight, Apgar scores, umbilical artery pH, and infectious morbidity were similar between groups.
CONCLUSION: More women achieved a favorable Bishop score at 6 and 12 hours after the start of cervical ripening with extra-amniotic saline infusion compared with dinoprostone gel. Saline infusion is as safe as dinoprostone gel for preinduction cervical ripening.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9932568     DOI: 10.1016/s0029-7844(98)00359-7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  1 in total

1.  Induction of labor and risk of postpartum hemorrhage in low risk parturients.

Authors:  Imane Khireddine; Camille Le Ray; Corinne Dupont; René-Charles Rudigoz; Marie-Hélène Bouvier-Colle; Catherine Deneux-Tharaux
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.